Abstract：
BACKGROUND:Cancer is a major public health issue and represents a significant economic burden to health care systems worldwide. The objective of this analysis was to estimate phase-specific, 5-year and lifetime net costs for the 21 most prevalent cancer sites, and remaining tumour sites combined, in Ontario, Canada. METHODS:We selected all adult patients diagnosed with a primary cancer between 1997 and 2007, with valid ICD-O site and histology codes, and who survived 30 days or more after diagnosis, from the Ontario Cancer Registry (N = 394,092). Patients were linked to treatment data from Cancer Care Ontario and administrative health care databases at the Institute for Clinical and Evaluative Sciences. Net costs (i.e., cost difference between patients and matched non-cancer control subjects) were estimated by phase of care and sex, and used to estimate 5-year and lifetime costs. RESULTS:Mean net costs of care (2009 CAD) were highest in the initial (6 months post-diagnosis) and terminal (12 months pre-death) phases, and lowest in the (3 months) pre-diagnosis and continuing phases of care. Phase-specific net costs were generally lowest for melanoma and highest for brain cancer. Mean 5-year net costs varied from less than $25,000 for melanoma, thyroid and testicular cancers to more than $60,000 for multiple myeloma and leukemia. Lifetime costs ranged from less than $55,000 for lung and liver cancers to over $110,000 for leukemia, multiple myeloma, lymphoma and breast cancer. CONCLUSIONS:Costs of cancer care are substantial and vary by cancer site, phase of care and time horizon analyzed. These cost estimates are valuable to decision makers to understand the economic burden of cancer care and may be useful inputs to researchers undertaking cancer-related economic evaluations.
journal_name
BMC Cancerjournal_title
BMC cancerauthors
de Oliveira C,Pataky R,Bremner KE,Rangrej J,Chan KK,Cheung WY,Hoch JS,Peacock S,Krahn MDdoi
10.1186/s12885-016-2835-7subject
Has Abstractpub_date
2016-10-18 00:00:00pages
809issue
1issn
1471-2407pii
10.1186/s12885-016-2835-7journal_volume
16pub_type
杂志文章相关文献
BMC CANCER文献大全abstract：BACKGROUND:It has been previously demonstrated in several cancer models, that Dronabinol (THC) may have anti-tumor activity--however, controversial data exists for acute leukemia. We have anecdotal evidence that THC may have contributed to disease control in a patient with acute undifferentiated leukemia. METHODS:To t...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-2029-8
更新日期：2016-01-16 00:00:00
abstract：BACKGROUND:Alterations in the redox balance are involved in the origin, promotion and progression of cancer. Inter-individual differences in the oxidative stress regulation can explain a part of the variability in cancer susceptibility.The aim of this study was to evaluate if polymorphisms in genes codifying for the di...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-861
更新日期：2014-11-21 00:00:00
abstract：BACKGROUND:Tyrosine kinase inhibitors are the first line standard of care for treatment of metastatic renal cell carcinoma (RCC). Accurate response assessment in the setting of antiangiogenic therapies remains suboptimal as standard size-related response criteria do not necessarily accurately reflect clinical benefit, ...
journal_title：BMC cancer
pub_type： 临床试验,杂志文章
doi：10.1186/s12885-017-3371-9
更新日期：2017-06-02 00:00:00
abstract：BACKGROUND:Invasive micropapillary carcinoma (IMPC) of the breast is a rare variant of invasive ductal carcinoma (IDC). The prognosis of IMPC compared with that of IDC remains controversial; we conducted a meta-analysis to evaluate the prognostic difference between IMPC and IDC. METHODS:We searched the PubMed, Cochran...
journal_title：BMC cancer
pub_type： 杂志文章,meta分析
doi：10.1186/s12885-017-3855-7
更新日期：2017-12-11 00:00:00
abstract：BACKGROUND:Patients undergone kidney transplantation present higher risk of Urothelial Carcinoma (UC) development and represent a subgroup of special interest. To date, vinflunine is the only drug approved in Europe for the treatment of advanced UC after failure of platinum-based chemotherapy. However, to our knowledge...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2666-6
更新日期：2016-08-12 00:00:00
abstract：BACKGROUND:Given their frequency of occurrence in the United States, cancer and heart disease often coexist. For patients requiring open-heart surgery, this raises concern that the use of cardiopulmonary bypass (CPB) may cause a transient immunosuppression with the potential to promote the spread and growth of coexisti...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-519
更新日期：2013-11-03 00:00:00
abstract：BACKGROUND:Vascular endothelial growth factor (VEGF) is a potent mitogen for endothelial cells, and its expression has been correlated with increased tumour angiogenesis. Although numerous publications dealing with the measurement of circulating VEGF for diagnostic and therapeutic monitoring have been published, the re...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-5-128
更新日期：2005-10-04 00:00:00
abstract：BACKGROUND:Several studies have described an increased cyclooxygenase-2 (COX-2) expression in pancreatic cancer, but the role of COX-2 in tumour development and progression is not clear. The aim of the present study was to examine expression of COX-2 in cancer cells and stromal cells in pancreatic cancer specimens, and...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-413
更新日期：2014-06-09 00:00:00
abstract：BACKGROUND:Prostate cancer displays different morphologies which, in turn, affect patient outcome. This fact prompted questions about the lineage relationship between differentiated, more treatable prostate adenocarcinoma and poorly differentiated, less treatable non-adenocarcinoma including small cell carcinoma, and t...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5680-7
更新日期：2019-05-30 00:00:00
abstract：BACKGROUND:To investigate the implications of prophylactic intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with D2 radical gastrectomy for locally advanced Gastric Cancer (AGC) in a randomized case control study. METHOD:Eighty consecutive patients with locally AGC were randomly separated into 2 groups...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6125-z
更新日期：2019-09-18 00:00:00
abstract：BACKGROUND:The present study evaluated the expression of hepcidin mRNA in hepatocellular carcinoma (HCC). METHODS:Samples of cancerous and non-cancerous liver tissue were taken from 40 patients with HCC who underwent hepatectomy. Expression of hepcidin mRNA was evaluated by real-time PCR, and compared in tumors differ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-8-167
更新日期：2008-06-09 00:00:00
abstract：BACKGROUND:Angipoietin-1 activation of the tyrosine kinase receptor Tek expressed mainly on endothelial cells leads to survival and stabilization of endothelial cells. Studies have shown that Angiopoietin-1 counteracts permeability induced by a number of stimuli. Here, we test the hypothesis that loss of Angiopoietin-1...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3531-y
更新日期：2017-08-11 00:00:00
abstract：BACKGROUND:Deciphering the meaning of the human DNA is an outstanding goal which would revolutionize medicine and our way for treating diseases. In recent years, non-coding RNAs have attracted much attention and shown to be functional in part. Yet the importance of these RNAs especially for higher biological functions ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6338-1
更新日期：2019-12-03 00:00:00
abstract：BACKGROUND:The purpose of this study was to investigate the impact of the Controlling Nutritional Status (CONUT) score on survival compared with the platelet to lymphocyte ratio (PLR), the neutrophil to lymphocyte ratio (NLR), and the Glasgow Prognostic Score (GPS) in patients with resectable thoracic esophageal squamo...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2696-0
更新日期：2016-09-06 00:00:00
abstract：BACKGROUND:In Brazil, the rate of cervical cancer remains high despite the availability of screening programs. With ongoing vaccine development and implementation, information on the prevalence of specific HPV types is needed, particularly among high-risk populations, such as HIV-infected women. METHODS:We performed a...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1486-4
更新日期：2015-06-23 00:00:00
abstract：BACKGROUND:Solid tumours are less oxygenated than normal tissues. This is called tumour hypoxia and leads to resistance to radiotherapy and chemotherapy. The molecular mechanisms underlying such resistance have been investigated in a range of tumour types, including the adult brain tumours glioblastoma, yet little is k...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5476-9
更新日期：2019-04-03 00:00:00
abstract：BACKGROUND:Lymphovascular invasion (LVI) is a vital risk factor for prognosis across cancers. We aimed to develop a scoring system for stratifying LVI risk in patients with breast cancer. METHODS:A total of 301 consecutive patients (mean age, 49.8 ± 11.0 years; range, 29-86 years) with breast cancer confirmed by patho...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-6578-0
更新日期：2020-02-03 00:00:00
abstract：:Chimeric antigen receptor T (CAR-T) cells are a promising new treatment for patients with relapsed or refractory hematologic malignancies, including lymphoma. Given the success of CAR-T cells directed against CD19, new targets are being developed and tested, since not all lymphomas express CD19. CD30 is promising targ...
journal_title：BMC cancer
pub_type： 杂志文章,评审
doi：10.1186/s12885-019-5415-9
更新日期：2019-03-06 00:00:00
abstract：BACKGROUND:It remains unknown whether primary ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is a homogeneous entity, as there are few reports of the results of cytogenetic or molecular analyses of these tumors. METHODS:We performed interphase fluorescence ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-6-249
更新日期：2006-10-20 00:00:00
abstract：BACKGROUND:Population attributable risks (PARs) are useful tool to estimate the burden of risk factors in cancer incidence. Few studies estimated the PARs of oral cavity cancer to tobacco smoking alone, alcohol drinking alone and their joint consumption but none performed analysis stratified by subsite, gender or age. ...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究
doi：10.1186/s12885-015-1841-5
更新日期：2015-10-31 00:00:00
abstract：BACKGROUND:Currently the majority of cancer patients are considered ineligible for intensive care treatment and oncologists are struggling to get their patients admitted to intensive care units. Critical care and oncology are frequently two separate worlds that communicate rarely and thus do not share novel development...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-612
更新日期：2010-11-08 00:00:00
abstract：BACKGROUND:Colorectal peritoneal carcinomatosis (CRPC) is a common form of systemic metastasis of intra-abdominal cancers. Intraperitoneal chemotherapy is a preferable option for colorectal cancer. Here we reported that a new system, 5-FU-loaded hydrogel system, can improve the therapeutic effects of intraperitoneal ch...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-402
更新日期：2010-08-02 00:00:00
abstract：BACKGROUND:B7-H4, a co-inhibitory molecule of the B7 family, can restrain T cell proliferation, cytokine secretion and the development of cytotoxicity. B7-H4 is expressed in tumor tissues at a higher level than in normal tissues, and has a potential effect to protect tumors from anti-tumor immune responses. This case-c...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-394
更新日期：2009-11-11 00:00:00
abstract：BACKGROUND:Vascular endothelial growth factor (VEGF) isoforms, particularly the diffusible VEGF-121, could play a major role in the response of recurrent glioblastoma (GB) to anti-angiogenetic treatment with bevacizumab. We hypothesized that circulating VEGF-121 may reduce the amount of bevacizumab available to target ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4442-2
更新日期：2018-05-10 00:00:00
abstract：BACKGROUND:18F-FDG PET/CT could satisfactorily show pancreatic and extra-pancreatic lesions in AIP, which can be mistaken for pancreatic cancer (PC). This study aimed to identify 18F-FDG PET/CT findings that might differentiate AIP from PC. METHODS:FDG-PET/CT findings of 26 AIP and 40 PC patients were reviewed. Pancre...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3665-y
更新日期：2017-10-23 00:00:00
abstract：BACKGROUND:Hepatocellular carcinoma (HCC) patients with hepatic vein tumor thrombosis (HVTT) extending to the inferior vena cava (IVC) have an extremely poor prognosis. Here we report a case of HCC with HVTT and renal dysfunction after hepatic arterial infusion chemotherapy (HAIC) successfully treated by liver resectio...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2749-4
更新日期：2016-09-01 00:00:00
abstract：BACKGROUND:The aim of this study was to identify gene signatures and prognostic values of m6A methylation regulators in uveal melanoma (UM). METHODS:The RNA sequencing dataset and corresponding clinical information were downloaded from TCGA and GEO database. Based on the expression of m6A RNA methylation regulators, t...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07159-8
更新日期：2020-07-18 00:00:00
abstract：BACKGROUND:HtrA1 is expressed in a variety of normal human tissues and seems to be involved in numerous physiological processes as well as tumorigenesis. This study reports the results of a meta-analysis that was performed: to compare HtrA1 expression as mRNA and protein, in cancer tissue versus non-cancer tissue and t...
journal_title：BMC cancer
pub_type： 杂志文章,meta分析
doi：10.1186/s12885-018-4041-2
更新日期：2018-02-06 00:00:00
abstract：BACKGROUND:Colorectal cancer is a major public health issue worldwide. Interleukin-17 (IL-17) and Th17 (T-helper cell type 17)-related molecules are involved in tumor development and in resistance to bevacizumab, an anti-vascular endothelial growth factor monoclonal antibody used in association with chemotherapy in met...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3210-z
更新日期：2017-03-27 00:00:00
abstract：BACKGROUND:Ovarian carcinoma is a rarely curable disease, for which new treatment options are required. As agents that block HMG-CoA reductase and the mevalonate pathway, the statin family of drugs are used in the treatment of hypercholesterolemia and have been shown to trigger apoptosis in a tumor-specific manner. Rec...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-103
更新日期：2010-03-18 00:00:00
